Wolverine Trading
APYX icon

Wolverine Trading’s Apyx Medical APYX Stock Holding History

Wolverine Trading’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,433
Closed -$20.8K – 4746
2024
Q2 		$22K Sell
16,433
-10,669
-39% -$15.7K ﹤0.01% 4319
2024
Q1 		$36.9K Buy
+27,102
New +$57.6K ﹤0.01% 4269
2019
Q1 		– Sell
-15,808
Closed -$101K – 4478
2018
Q4 		$101K Sell
15,808
-569
-3% -$3.45K ﹤0.01% 3981
2018
Q3 		$116K Buy
+16,377
New +$91K ﹤0.01% 4485
2018
Q1 		– Sell
-17,092
Closed -$44K – 5076
2017
Q4 		$44K Buy
17,092
+3,036
+22% +$9.48K ﹤0.01% 4624
2017
Q3 		$48K Buy
+14,056
New +$36.3K ﹤0.01% 4234

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Trading's APYX Position: Q3 2024 in Review

Wolverine Trading sold out of Apyx Medical (APYX) in Q3 2024, closing a stake of 16,433 shares — an estimated $20.8K sold.

Wolverine Trading first reported a position in APYX in Q3 2017 and held it in 6 quarters. The position peaked at $116K in Q3 2018. 45 funds tracked by Wall St. Rank hold APYX as of Q3 2024.

  • Wolverine Trading reported no remaining Apyx Medical position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 16,433 Apyx Medical shares in Q3 2024, an estimated $20.8K.
  • Wolverine Trading first reported a position in Apyx Medical in Q3 2017 and held it in 6 quarters.
  • Wolverine Trading's Apyx Medical position peaked at $116K in Q3 2018.
  • 45 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.